BCM
MGCD

Bridgeway Capital Management’s MGC Diagnostics Corporation MGCD Stock Holding History

Bridgeway Capital Management’s Portfolio MGCD Stock Details MGCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-18,200
Closed -$207K – 1481
2014
Q1 		$207K Hold
18,200
– – 0.01% 1312
2013
Q4 		$230K Buy
+18,200
New +$222K 0.01% 1275

Other funds holding MGCD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFA
Nationwide Fund Advisors Columbus, Ohio $2.42B AUM 17.68% 1-Year Est. Return
HAMF
Hatteras Alternative Mutual Funds Raleigh, North Carolina $221M AUM 39.11% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bridgeway Capital Management's MGCD Position: Q2 2014 in Review

Bridgeway Capital Management sold out of MGC Diagnostics Corporation (MGCD) in Q2 2014, closing a stake of 18,200 shares — an estimated $207K sold.

Bridgeway Capital Management first reported a position in MGCD in Q4 2013 and held it in 2 quarters. The position peaked at $230K in Q4 2013. 19 funds tracked by Wall St. Rank hold MGCD as of Q2 2014.

  • Bridgeway Capital Management reported no remaining MGC Diagnostics Corporation position as of Q2 2014 after selling out during the quarter.
  • Bridgeway Capital Management sold 18,200 MGC Diagnostics Corporation shares in Q2 2014, an estimated $207K.
  • Bridgeway Capital Management first reported a position in MGC Diagnostics Corporation in Q4 2013 and held it in 2 quarters.
  • Bridgeway Capital Management's MGC Diagnostics Corporation position peaked at $230K in Q4 2013.
  • 19 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q2 2014.

Based on Bridgeway Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.